SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001625101-21-000021
Filing Date
2021-05-10
Accepted
2021-05-10 16:23:48
Documents
13
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20210510x8k.htm   iXBRL 8-K 74152
2 EX-99.1 plse-20210510xex99_1.htm EX-99.1 218596
  Complete submission text file 0001625101-21-000021.txt   433058

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20210510.xsd EX-101.SCH 3003
4 EX-101.LAB plse-20210510_lab.xml EX-101.LAB 15512
5 EX-101.PRE plse-20210510_pre.xml EX-101.PRE 11495
6 EXTRACTED XBRL INSTANCE DOCUMENT plse-20210510x8k_htm.xml XML 4813
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 21907566
SIC: 3841 Surgical & Medical Instruments & Apparatus